Since #Hydroxychloroquine is trending, it's a good time to share some information I've been collecting about conflicts of interest involving studies on it.
Thread
1/x
Thread
1/x
One of the most underreported stories about the pandemic - and more generally as newsworthy information - is the repeated occurrence and influence of major conflicts of interest in the study of Hydroxychloroquine as a treatment for covid-19...
2/x
2/x
...specifically by people with financial ties to Gilead Sciences, the company that manufactures Remdesivir, a drug whose only major competition as a treatment for covid-19 right now is Hydroxychloroquine.
Below are several examples of such conflicts of interest.
3/x
Below are several examples of such conflicts of interest.
3/x
1.
2.thenewamerican.com/usnews/health-…
"Alarmingly, the study’s author, Scott Sutton, has been
paid to do three studies for Gilead Sciences, Inc.,
maker of Remdesivir, also a drug in trials to treat
COVID-19!"
4/x
2.thenewamerican.com/usnews/health-…
"Alarmingly, the study’s author, Scott Sutton, has been
paid to do three studies for Gilead Sciences, Inc.,
maker of Remdesivir, also a drug in trials to treat
COVID-19!"
4/x
3."Undisclosed is the fact that the two lead co-authors both have significant, relevant financial conflicts of interest that more than likely biased the reported findings."
ahrp.org/the-lancet-pub…
5/x
ahrp.org/the-lancet-pub…
5/x
3. (continued) "Dr. Mandeep Mehra, the lead co-author is a director at Brigham & Women’s Hospital, which is credited with funding the study."
6/x
6/x
3. (continued) "Dr. Mehra and The Lancet failed to disclose that Brigham Hospital has a partnership with Gilead and is currently conducting TWO trials testing Remdesivir, the prime competitor of hydroxychloroquine for the treatment of COVID-19, the focus of the study."
7/x
7/x
